Compound Detail
CHEMBL5201147
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5201147 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AFIRFXBVUTVJNE-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
355.4
MW (Da)
3.89
ALogP
6
HBA
3
HBD
102.3
PSA (Ų)
0.50
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.08
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| High affinity nerve growth factor receptor CHEMBL2815 | IC50 | 7.08 | 7.08 | 83.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| High affinity nerve growth factor receptor | IC50 | = | 83.0 | nM | 7.08 | Inhibition of N-terminal human TRKA (436 to 790 residues) expressed in baculovir... | 35617855 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35617855 | 10.1016/j.ejmech.2022.114451 | High affinity nerve growth factor receptor | 1 |
Data from ChEMBL 36 via Core Engine